Fact CheckerSign in

NCT07676305Recruiting

6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics

Impact of 6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics in Adults withT2D

Source: ClinicalTrials.gov · Last updated 2 Nov 2026

Brief summary (registry, in English)

To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
23 Jun 2026
Start date
11 Feb 2026
Primary completion date
31 Dec 2027
Lead sponsor
University of British Columbia
NCT number
NCT07676305

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 11 Feb 2026 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise.
  • Unstable type 2 diabetes medication of the last 3 months C. Absolute contraindications to BFR (i.e., peripheral vascular disease) D. A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions E. A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis) F. Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely G. Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity

Who the study is looking for

  • Aged 19-64 years. B. Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0% C. Completing \<150 minutes of moderate-vigorous physical activity per week.

Age in the registry: 19 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of British Columbia Okanagan
Coordinator of this site? Confirm its status
KelownaCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.